Press releases

Sep 6

Sachi Bio’s New Treatment Featured by Multiple Media Outlets: A “game-changing tool” in fight against Alzheimer’s, Dementia, and Aging

KEYWORDS: Alzheimer’s, aging, dementia, treatment, Nanoligomer Read more at: Denver Post Colorado State University Press release DENVER -...

Sep 2

Age-reversing effects of Sachi's Drug Molecule published in the Journal of Neuroinflammation

As the brain gets older or in conditions like Alzheimer’s, inflammation becomes a major problem that damages brain cells, leading to...

Aug 15

The Future is Here: Sachi Bio Advances Space-based Drug Discovery

In the realm of pharmaceuticals, the pursuit of innovation knows no bounds. Scientists and researchers constantly strive to leverage...

Apr 15

Sachi Bio wins NASA Phase IIE and III contracts to Develop Neuroprotective Countermeasures for Long-term Space travel

Sachi Bio won Phase IIE and Phase III contracts from the NASA Human Research Program to continue advancement of the Neurotherapeutic...

Mar 31

Investigational New Drug (IND)-enabling Studies for Sachi Bio's lead molecule

Sachi Bio's lead program NI112 shows excellent Safety-Toxicity, brain-delivery, and biodistribution profile in Investigational New Drug...

Jan 31

Sachi Bio lead programs to support NASA Missions & counter debilitating diseases on Earth

"Sachi Bio has successfully advanced it's lead program towards translation for a range of neurodegenerative diseases, as well as a...

Nov 30, 2023

Sachi Bio wins US National Academy of Medicine Sponsored "Healthy Longevity Global Challenge" for Healthy Aging

Starting in 2030, we will witness a historic milestone as the elderly population surpasses the youth for the first time ever. This...

Nov 10, 2023

Sachi Bio's Research into Exploring Brain Aging in Space flies on SpaceX CRS-29

Sachi Bio is sending samples to International Space Station (ISS) Labs to study the effect of microgravity on brain aging and disease...

Aug 31, 2023

Sachi Bio presents at ISSR&D Conference as it aims to become the first company in the world to test RNA Therapeutics in Space

Sachi Bio presented data on human brain organoids and their treatment with Nanoligomers, to the space community in the ISSR&D conference...

Jul 31, 2023

Sachi Bio awarded SBIR Phase III contract from NASA for Rapid, Low-Cost Drug-Discovery in Space

Sachi Bio has been selected to provide potential scientific and commercialization evidence for use of accelerated aging and...

Mar 31, 2023

Sachi's NanoligomerTM platform can deliver to the brain with systemic administration

Brain delivery of Nanoligomer using systemic administration What if you could deliver RNA therapeutics to the brain for high-precision...

Ph: 720-361-2159

3000 Airport Drive, Unit 201,

Erie, CO 80516

Subscribe to Our Newsletter